Inflammation Jobs In Germany - 109 Job Positions Available

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms

The FTE Medical Writer will serve as an integrated member of the team, delivering medical writing services for the development of clinical documents, including Clinical Trial Reports (CTRs), Trial Design Outlines/Clinical Trial Protocols (TDOs/CTPs) and CTP

Wir stellen Medikamente und Impfstoffe für die ganze Welt her und unsere Teams betreuen jeden Produktionsprozess. Dazu gehört die Erstellung qualitativ hochwertiger Produkte an unseren Produktionsstandorten sowie die Planung effektiver Bedarfsprognosen und behördlicher Inspektionen, alles unterstützt

The Position At Boehringer Ingelheim, we are committed to transforming the lives of patients suffering from severe pulmonary diseases. We are seeking a highly motivated and talented Postdoctoral Scientist to join our Vascular Health Cluster within

About Beeline Medicines: Beeline Medicines is a clinical‑stage biotechnology company focused on developing and delivering category-leading precision therapies to transform the lives of people living with autoimmune and inflammatory diseases. With a portfolio of potential best-in-class

Wir stellen Medikamente und Impfstoffe für die ganze Welt her und unsere Teams betreuen jeden Produktionsprozess. Dazu gehört die Erstellung qualitativ hochwertiger Produkte an unseren Produktionsstandorten sowie die Planung effektiver Bedarfsprognosen und behördlicher Inspektionen, alles unterstützt

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms

We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 million vaccine

Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the

Head Finance Business Partner Specialty Business Introduction GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the

Exzellenzcluster „Precision Medicine in Chronic Inflammation“ (PMI) Der Exzellenzcluster „Precision Medicine in Chronic Inflammation“ (PMI) bietet wissenschaftlich interessierten Ärztinnen und Ärzten optimale Karrierechancen und langfristige Entwicklungsperspektiven. Nach mehreren erfolgreichen Förderperioden in der Exzellenzinitiative und dem erneuten Erfolg in

Exzellenzcluster „Precision Medicine in Chronic Inflammation“ (PMI) Der Exzellenzcluster „Precision Medicine in Chronic Inflammation“ (PMI) bietet wissenschaftlich interessierten Ärztinnen und Ärzten optimale Karrierechancen und langfristige Entwicklungsperspektiven. Nach mehreren erfolgreichen Förderperioden in der Exzellenzinitiative und dem erneuten Erfolg in

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the